Life Insurance Corp. has reduced its shareholding in Lupin Ltd. by nearly half. The drugmaker intimated to stock exchanges that LIC divested 2.027% equity or over 92 lakh shares.
LIC's equity stake in Lupin now stands at 2.542%, down from the previous 4.569%.
The share sale was conducted between Sept. 30 and Dec. 6, according to an exchange filing.
Domestic mutual funds account for 16.89% of Lupin's shareholding, while insurance companies have 7.2%, as of the end of September.
SBI Life Insurance Co. holds 1.04%, and HDFC Life Insurance Co. has 1.38% equity.
LIC is one of India's major institutional investors.
In the second quarter of the current financial year, Lupin reported a 13% revenue rise to Rs 5,672.7 crore as compared to Rs 5,038.6 crore in the same period a year ago. Net profit rose 74% year-on-year to Rs 852.6 crore versus Rs 489.7 crore.
The company’s US business grew 6% YoY but dipped sequentially. The pharma major posted sales of $220 million, compared to $213 million last year. Lupin had recorded sales of $227 million in Q1FY25.
Shares of Lupin Ltd. closed 1.21% lower at Rs 2,106.65 on Monday, while benchmark Nifty 50 ended 0.24% lower. The stock has risen 70% in the last 12 months.
Twenty out of the 37 analysts tracking Lupin have a 'buy' rating on the stock, 10 recommend a 'hold,' and seven suggest a 'sell,' according to Bloomberg data. The average of the 12-month analyst price target of Rs 2,254 implies a potential upside of 7%.
RECOMMENDED FOR YOU
Indigo Delhi-Pune Flight Faces Over Four-Hour Delay As Pilot Falls Sick Before Takeoff
Jul 05, 2025
Can You Take A Loan Against LIC Policy? Essential Factors To Know Before Borrowing
Jul 02, 2025
Trade Body Raises Concern Over Rising Health Insurance Premiums, Writes To Finance Minister
Jun 26, 2025
US Strikes On Iran: How Markets Will Trade
Jun 22, 2025
POPULAR